Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

LEL

Lilly(Eli) (LEL)

Lilly(Eli)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:LEL
DatumZeitQuelleÜberschriftSymbolFirma
30/01/201415h27PR Newswire (US)LILLY (ELI) & COMPANY - 4th Quarter EarningsLSE:LELLilly(Eli)
25/07/201308h00PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
08/07/201316h17PR Newswire (US)LILLY (ELI) & COMPANY - Form 8-KLSE:LELLilly(Eli)
08/05/201316h06PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8K FilingLSE:LELLilly(Eli)
07/05/201316h22PR Newswire (US)LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgeryLSE:LELLilly(Eli)
03/05/201308h00PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
03/05/201308h00PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
24/04/201317h31PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingLSE:LELLilly(Eli)
28/03/201314h35UK RegulatoryLilly (Eli) & Co Cancellation of ListingLSE:LELLilly(Eli)
28/03/201314h35PR Newswire (US)LILLY (ELI) & COMPANY - Cancellation of ListingLSE:LELLilly(Eli)
28/03/201309h00UK RegulatoryOfficial List Cancellation Lilly (Eli) & CompanyLSE:LELLilly(Eli)
26/03/201317h01PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
26/03/201317h00PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of SharesLSE:LELLilly(Eli)
27/02/201318h06PR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel ListingLSE:LELLilly(Eli)
07/02/201314h59PR Newswire (US)LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for TabalumabLSE:LELLilly(Eli)
29/01/201314h33PR Newswire (US)LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 ResultsLSE:LELLilly(Eli)
24/01/201319h24PR Newswire (US)LILLY (ELI) & COMPANY - Miscellaneous - Other SEC FilingsLSE:LELLilly(Eli)
24/01/201319h22PR Newswire (US)LILLY (ELI) & COMPANY - Holding(s) in CompanyLSE:LELLilly(Eli)
24/01/201319h21PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingsLSE:LELLilly(Eli)
24/01/201319h19PR Newswire (US)LILLY (ELI) & COMPANY - Director/PDMR ShareholdingLSE:LELLilly(Eli)
24/01/201319h16PR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementLSE:LELLilly(Eli)
24/01/201319h15PR Newswire (US)LILLY (ELI) & COMPANY - 3rd Quarter ResultsLSE:LELLilly(Eli)
24/01/201319h13PR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
24/01/201319h12PR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
24/01/201319h11PR Newswire (US)LILLY (ELI) & COMPANY - Annual Financial ReportLSE:LELLilly(Eli)
24/01/201319h02PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2012LSE:LELLilly(Eli)
24/01/201318h39PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2011LSE:LELLilly(Eli)
24/01/201318h37PR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2010LSE:LELLilly(Eli)
16/01/201308h00PR Newswire (US)LILLY (ELI) & COMPANY - Amyvid Approved in European UnionLSE:LELLilly(Eli)
07/01/201315h11PR Newswire (US)LILLY (ELI) & COMPANY - Phase III data results for empagliflozinLSE:LELLilly(Eli)
 Showing the most relevant articles for your search:LSE:LEL